Improving Immunotherapy Through Glycodesign

Immunotherapy is revolutionizing health care, with the majority of high impact “drugs” approved in the past decade falling into this category of therapy. Despite considerable success, glycosylation—a key design parameter that ensures safety, optimizes biological response, and influences the pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Buettner, Matthew J., Shah, Sagar R., Saeui, Christopher T., Ariss, Ryan, Yarema, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224361/
https://www.ncbi.nlm.nih.gov/pubmed/30450094
http://dx.doi.org/10.3389/fimmu.2018.02485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224361/
https://www.ncbi.nlm.nih.gov/pubmed/30450094
http://dx.doi.org/10.3389/fimmu.2018.02485

Ejemplares similares